Who owns Genes?

Key details on Genes (Ticker: GCO)

Who owns Genes?

Is GCO a good stock to own? Find out who bought Genes, who sold Genes (GCO) stock, and who holds a large position in Genes.

Fund Name Number of Shares Share Valuation As Of
FMR 3.60M $237.72M June 30, 2015
Damian Sousa 3.04M $201.05M June 30, 2015
Royce & Associates 2.05M $135.24M June 30, 2015
Vanguard 1.66M $109.40M June 30, 2015
BlackRock Fund Advisors 1.39M $91.67M June 30, 2015
Charles Schwab Bank 818666 $13.62M March 31, 2013
DIMENSIONAL FUND ADVISORS 809055 $57.63M March 31, 2015
Franklin Resources 691358 $45.65M June 30, 2015
STATE STREET CORPORATION 681640 $45.01M June 30, 2015
LORD, ABBETT & CO 643787 $49.33M Dec. 31, 2014
CHILTON INVESTMENT 632377 $41.47M Sept. 30, 2013
Vinik Asset Management 603889 $36.32M June 30, 2012
LOMBARDIA CAPITAL PARTNERS 600277 $39.64M June 30, 2015
Cambiar Investors 597221 $39.43M June 30, 2015
Pembroke Management 578500 $42.27M Dec. 31, 2013
BlackRock Institutional Trust Company, N.A. 562988 $37.17M June 30, 2015
Buckingham Capital Management 561826 $37.49M Sept. 30, 2012
Columbus Circle Investors 537205 $35.85M Sept. 30, 2012
FRIESS ASSOCIATES 535600 $33.07M Dec. 31, 2011
Inves 525088 $32.42M Dec. 31, 2011
Ranger Investment Management 521640 $34.81M Sept. 30, 2012

Who sold Genes?

Fund Name Date Sold Number of Shares Sold Share Valuation
First Trust Advisors June 30, 2011 597623 $31.14M
Ameriprise Financial June 30, 2011 542485 $28.26M
Wells Fargo & Company March 31, 2011 1.11M $44.33M
Norges Bank Investment Management March 31, 2011 676347 $27.19M
Manufacturers Life Insurance Company Dec. 31, 2002 555028 $17.27M